强力宁联合小剂量阿维A治疗银屑病120例临床研究观察

目的：探讨强力宁联合小剂量阿维A治疗银屑病的临床疗效。方法：选取2014年7月～2016年1月在我院接受治疗的寻常型银屑病患者120例为研究对象，分为强力宁联合阿维A组及强力宁联合小剂量阿维A组，每组60例。比较治疗前后两组临床疗效、肝肾功能、血脂及用药不良反应情况。结果：强力宁联合小剂量阿维A组治疗总有效率为73.3%，显著高于强力宁联合阿维A组（P<0.05），差异有统计学意义。治疗过程中不良反应发生率为6.6%，显著低于强力宁联合阿维A组（P<0.05）。结论：强力宁联合小剂量阿维A治疗寻常型银屑病疗效好，毒副作用少，值得临床推广。

The observe of the clinical therapeutic effect on the treatment of Psoriasis with potenlin combined with low-dose acitretin

Objective: To explore the clinical therapeutic effect on the treatment of Psoriasis with potenlin combined with low-dose acitretin. Methods: 120 cases of Psoriasis vulgaris were divided into potenlin combined with acitretin group and potenlin combined with low-dose acitretin group according to different treating methods. To compare clinical curative effect and drug adverse reactions. Results:The total effective rate of potenlin combined with low-dose acitretin group was 73.3%, significantly higher than the other group (P<0.05), the difference was statistically significant, the incidence of adverse reactions in the process of treatment was 6.6%, significantly lower than the other group(P<0.05). Conclusion:Potenlin combined with low-dose acitretin has better treatment of psoriasis vulgaris and less side effects.